Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of $76.15 billion as of July 31, 2026. Its market cap has increased by 27.18% in one year.

• Market Cap: 76.15B
• Enterprise Value: 61.04B
• 1-Year Change: 27.18%
• Ranking: #231
• Category: Large-Cap
• Stock Price: $762.63

Market Cap Chart

Chart

Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $76.15B, an increase of 30,119.21%. That is a compound annual growth rate of 22.91%.

Market Cap History

Date	Market Cap	% Change
Jul 31, 2026	78.52B	-3.21%
Dec 31, 2025	81.12B	3.64%
Dec 31, 2024	78.28B	-18.19%
Dec 29, 2023	95.69B	21.78%
Dec 30, 2022	78.57B	15.69%
Dec 31, 2021	67.92B	31.74%
Dec 31, 2020	51.55B	25.04%
Dec 31, 2019	41.23B	1.98%
Dec 31, 2018	40.43B	0.08%
Dec 29, 2017	40.39B	4.33%
Dec 30, 2016	38.72B	-31.47%
Dec 31, 2015	56.49B	35.45%
Dec 31, 2014	41.71B	52.42%
Dec 31, 2013	27.36B	65.66%
Dec 31, 2012	16.52B	221.91%
Dec 30, 2011	5.13B	89.94%
Dec 31, 2010	2.70B	38.80%
Dec 31, 2009	1.95B	33.11%
Dec 31, 2008	1.46B	-8.46%
Dec 31, 2007	1.60B	38.55%
Dec 29, 2006	1.15B	29.12%
Dec 30, 2005	893.00M	73.94%
Dec 31, 2004	513.40M	-36.89%
Dec 31, 2003	813.50M	-0.20%
Dec 31, 2002	815.10M	-33.81%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 31, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Aug 2, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Vertex Pharmaceuticals	121.80B
argenx SE	53.75B
Revolution Medicines	40.18B
BeOne Medicines AG	35.06B
Royalty Pharma	33.74B
Alnylam Pharmaceuticals	27.47B
Incyte	24.35B
Roivant Sciences	24.25B